Joachim Marien

Dr. Joachim Marien

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Journal of Virological Methods
Verified
Journal Article
Open access
JMJoachim Marien
Joachim Marien
ACAnn Ceulemans
Ann Ceulemans
JMJohan Michiels
Johan Michiels
LHLeo Heyndrickx
Leo Heyndrickx
KKKaren Kerkhof
Karen Kerkhof
KAKevin Arien
Kevin Arien
Large-scale serosurveillance of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) will only be possible if serological tests are sufficiently reliable, rapid and affordable. Many assays are either labour-intensive and require specialised facilities (e.g. virus neutralization assays), or are expensive with suboptimal specificity (e.g. commercial ELISAs and RDTs). Bead-based assays offer a cost-effective alternative and allow for multiplexing to test for antibodies against multiple antigens and against other pathogens. Here, we compare the performance of spike (S) and nucleocapsid (NP) antigens for the detection of SARS-CoV-2 specific IgG, IgM and IgA antibodies in a panel of sera that includes recent (up to six weeks after symptom onset, severe n = 44; and mild cases n = 52) and old infections (five months after symptom onset, mild n = 104), using a Luminex-bead based assay and comparison to a virus neutralization test. While we show that neutralizing antibody levels are significantly lower in mild than in severe cases, we demonstrate that a combination of the recombinant nucleocapsid protein (NP) and receptor-binding domain (RBD) results in highly specific (99 %) IgG antibody detection five months after infection in 96 % of cases. Although most severe Covid-19 cases developed a clear IgM and IgA response, titers fell below the detection threshold in more than 20 % of mild cases in our bead-based assay. In conclusion, our data supports the use of RBD and NP for the development of SARS-CoV-2 serological IgG bead-based assays.

1 January 2019 in Emerging Microbes & Infections
Verified
Journal Article
Open access
JMJoachim Marien
Joachim Marien
BBBenny Borremans
Benny Borremans
FKFodé Kourouma
Fodé Kourouma
JBJatta Baforday
Jatta Baforday
TRToni Rieger
Toni Rieger
EFElisabeth Fichet-Calvet
Elisabeth Fichet-Calvet
The Natal multimammate mouse (Mastomys natalensis) is the reservoir host of Lassa virus, an arenavirus that causes Lassa haemorrhagic fever in humans in West Africa. Because no vaccine exists and therapeutic options are limited, preventing infection through rodent control and human behavioural measures is currently considered to be the only option. In order to assess the efficacy of rodent control, we performed a 4-year field experiment in rural Upper Guinea and developed a mathematical model to simulate different control strategies (annual density control, continuous density control, and rodent vaccination). For the field study, rodenticide baits were placed each year in three rural villages, while three other villages were used as controls. Rodents were trapped before and after every treatment and their antibody status and age were determined. Data from the field study were used to parameterize the mathematical model. In the field study, we found a significant negative effect of rodent control on seroprevalence, but this effect was small especially given the effort. Furthermore, the rodent populations recovered rapidly after rodenticide application, leading us to conclude that an annual control strategy is unlikely to significantly reduce Lassa virus spillover to humans. In agreement with this finding, the mathematical model suggests that the use of continuous control or rodent vaccination is the only strategy that could lead to Lassa virus elimination. These field and model results can serve as a guide for determining how long and frequent rodent control should be done in order to eliminate Lassa virus in rural villages.

23 March 2018 in Ecohealth
Verified
Journal Article
Closed access
PDF file
JMJoachim Marien
Joachim Marien
FKFodé Kourouma
Fodé Kourouma
NMN’fAly Magassouba
N’fAly Magassouba
HLHerwig Leirs
Herwig Leirs
EFElisabeth Fichet-Calvet
Elisabeth Fichet-Calvet

1 January 2020 in Emerging Microbes & Infections
Verified
Journal Article
Open access
JMJoachim Marien
Joachim Marien
GIGiovanni Lo Iacono
Giovanni Lo Iacono
TRToni Rieger
Toni Rieger
NMNfaly Magassouba
Nfaly Magassouba
SGStephan Günther
Stephan Günther
EFElisabeth Fichet-Calvet
Elisabeth Fichet-Calvet
The Natal multimammate mouse (Mastomys natalensis) is the reservoir host of Lassa virus (LASV), an arenavirus that causes Lassa haemorrhagic fever in humans in West Africa. While previous studies suggest that spillover risk is focal within rural villages due to the spatial behaviour of the rodents, the level of clustering was never specifically assessed. Nevertheless, detailed information on the spatial distribution of infected rodents would be highly valuable to optimize LASV-control campaigns, which are limited to rodent control or interrupting human–rodent contact considering that a human vaccine is not available. Here, we analysed data from a four-year field experiment to investigate whether LASV-infected rodents cluster in households in six rural villages in Guinea. Our analyses were based on the infection status (antibody or PCR) and geolocation of rodents (n = 864), and complemented with a phylogenetic analysis of LASV sequences (n = 119). We observed that the majority of infected rodents were trapped in a few houses (20%) and most houses were rodent-free at a specific point in time (60%). We also found that LASV strains circulating in a specific village were polyphyletic with respect to neighbouring villages, although most strains grouped together at the sub-village level and persisted over time. In conclusion, our results suggest that: (i) LASV spillover risk is heterogeneously distributed within villages in Guinea; (ii) viral elimination in one particular village is unlikely if rodents are not controlled in neighbouring villages. Such spatial information should be incorporated into eco-epidemiological models that assess the cost-efficiency of LASV control strategies.

1 November 2021 in Journal of Virological Methods
Verified
Journal Article
Closed access
JMJoachim Marien
Joachim Marien
JMJohan Michiels
Johan Michiels
LHLeo Heyndrickx
Leo Heyndrickx
Antoine Nkuba-NdayeAntoine Nkuba-Ndaye
Antoine Nkuba-Ndaye
ACAnn Ceulemans
Ann Ceulemans
KAKevin Arien
Kevin Arien

1 January 2020 in Emerging Microbes & Infections
Verified
Journal Article
Open access
PSPhilippe Selhorst
Philippe Selhorst
SMSheila Makiala-Mandanda
Sheila Makiala-Mandanda
BSBirgit De Smet
Birgit De Smet
JMJoachim Marien
Joachim Marien
CAColin Anthony
Colin Anthony
SASteve Ahuka-Mundeke
Steve Ahuka-Mundeke
Early 2019, a chikungunya virus (CHIKV) outbreak hit the Democratic Republic of the Congo (DRC). Though seldomly deadly, this mosquito-borne disease presents as an acute febrile (poly)arthralgia often followed by long-term sequelae. Although Aedes aegypti is the primary vector, an amino acid substitution in the viral envelope gene E1 (A226V) is causing concern as it results in increased transmission by Aedes albopictus, a mosquito with a much wider geographical distribution. Between January and March 2019, we collected human and mosquito samples in Kinshasa and Kongo Central province (Kasangulu and Matadi). Of the patients that were tested within 7 days of symptom onset, 49.7% (87/175) were RT-PCR positive, while in the mosquito samples CHIKV was found in 1/2 pools in Kinshasa, 5/6 pools in Kasangulu, and 8/26 pools in Matadi. Phylogenetic analysis on whole genome sequences showed that the circulating strain formed a monophyletic group within the ECSA2 lineage and harboured the A226V mutation. Our sequences did not cluster with sequences from previously reported outbreaks in the DRC nor with other known A226V-containing ECSA2 strains. This indicates a scenario of convergent evolution where A226V was acquired independently in response to a similar selection pressure for transmission by Ae. albopictus. This is in line with our entomological data where we detected Ae. albopictus more frequently than Ae. aegypti in two out of three affected areas. In conclusion, our findings suggest that CHIKV is adapting to the increased presence of Aedes albopictus in DRC.